Pfizer to cut 6,000 jobs in plant closures and downsizing
This article was originally published in Scrip
Pfizer has announced plans to close eight manufacturing sites in Ireland, Puerto Rico and the US by 2015, and to reduce operations at six further plants in Germany, Ireland, Puerto Rico, the UK and the US. Some other plants will be expanded, but overall the changes will reduce the number of people working at Pfizer Global Manufacturing by 18% from 33,000, and reduce the number of sites it operates by 15% from 78. The sites in question are active in a number of areas including solid-dose, aseptic, biotechnology and consumer healthcare manufacturing. Pfizer said it was also assessing its animal health production activities and would announce recommendations by the end of June. It will start to consider its nutrition and emerging markets plant network later in the year.